# Vicarious Surgical Inc.: overview RBOT · OTC · CIK 1812173 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/rbot.md) · [Financials](/companies/rbot/financials.md) · [Filings](/companies/rbot/filings.md) · [Insiders](/companies/rbot/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.10)](/filings/0001213900-24-037265.md) | [(2.59)](/filings/0001213900-24-067807.md) | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $m | [(14.5)](/filings/0001213900-25-042087.md) | [(11.0) d](/filings/0001213900-25-075049.md) | not reported | not reported | [(11.8)](/filings/0001213900-25-042087.md) | [(13.5) d](/filings/0001213900-25-075049.md) | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.36)](/filings/0001213900-23-011661.md) | [0.04](/filings/0001213900-24-019594.md) | [(0.49)](/filings/0001213900-24-019594.md) | not reported | not reported | | Free cash flow | $m | [(34.6)](/filings/0001213900-23-011661.md) | [(66.6)](/filings/0001213900-24-019594.md) | [(64.0)](/filings/0001213900-25-024588.md) | [(50.1)](/filings/0001213900-26-025189.md) | [(45.2)](/filings/0001213900-26-025189.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rbot/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [K5 Global Advisor LLC](/funds/2151773.md) | 2026-06-30 | $5.0k | 720 | | Not compared | ## Recent filings [All 693 filings](/companies/rbot/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-07-21 | 16:10 ET | [8-K](/filings/0001213900-26-080011.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-080011 | | 2026-06-24 | 17:21 ET | [8-K](/filings/0001213900-26-071589.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-071589 | | 2026-06-22 | 08:32 ET | [DEF 14A](/filings/0001213900-26-070393.md) | Proxy statement, period 2026-07-21 | 0001213900-26-070393 | | 2026-04-30 | 08:30 ET | [10-Q](/filings/0001213900-26-049749.md) | Quarterly report, period 2026-03-31 | 0001213900-26-049749 | | 2026-04-08 | 16:30 ET | [8-K](/filings/0001213900-26-041522.md) | 5.07 Shareholder vote results | 0001213900-26-041522 | | 2026-04-06 | 19:01 ET | [SCHEDULE 13D/A](/filings/0001720215-26-000003.md) | Ownership report, active investor, amended | 0001720215-26-000003 | | 2026-03-23 | 16:30 ET | [DEF 14A](/filings/0001213900-26-032944.md) | Proxy statement, period 2026-04-08 | 0001213900-26-032944 | | 2026-03-09 | 16:17 ET | [8-K](/filings/0001213900-26-025193.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-025193 | | 2026-03-09 | 16:16 ET | [10-K](/filings/0001213900-26-025189.md) | Annual report, period 2025-12-31 | 0001213900-26-025189 | | 2026-03-06 | 16:30 ET | [8-K](/filings/0001213900-26-024707.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-024707 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-025189.md), filed Mar 9, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1812173 - Tickers: RBOT - Exchange: OTC - SIC code: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.